Hepatitis Vaccine Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC621


Hepatitis vaccine is an antidote for hepatitis disease. Hepatitis B, a life endangering liver infection, is caused by hepatitis B virus, and this vaccine is the solitary highly effective method of preventing this infection in comparison to any other available treatment. As per the World Health Organization (WHO), the prevalence of hepatitis infection is the most across Western Pacific and African region and the least across America.

Market Dynamics

The global hepatitis vaccine market is analyzed to be affected by a number of factors. As indicated over the years by WHO, this disease takes place in infants. The rising number of cases of Hepatitis-B virus is key factor driving the need for this vaccine currently. The appreciable rise in the awareness of hepatitis infection prevention among people coupled with numerous governments across the globe rolling out hepatitis immunization and vaccination policies within their national immunization schedules are the factors analyzed to boost the market growth for hepatitis vaccine, globally. Due to the availability of fewer antibiotics, only this vaccine immunes from the disease. Also, it's medical treatment and medicines are highly expensive. These are the major factors analyzed to hinder the growth of hepatitis vaccine market worldwide.

Market Classification

The global hepatitis vaccine market is classified by products into Hepatitis B vaccine, Anti-Viral Drugs, Lamivudine, Famciclovir, Acyclovir, Fascornet, Adefovir, Telbivudine, Acyclovir, Entecavir, and Tenofovir. Furthermore, the market is bifurcated based on end use into hospitals pharmacies, pharmacies and drug stores, clinics. Lastly, the global market is partitioned on the basis of geography into North America, Latin America, Europe, Asia-Pacific and Middle East & Africa (MEA).

Report Coverage


Hepatitis Vaccine Market-

Analysis Period

2015 - 2026

Historic Data

2015 – 2016

Base Year


Forecast Data

2018 – 2026

Market Stratification

Product, End Use, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

Market Participants

Some of the key players in the hepatitis vaccine market are Bristol-Myers Squibb, Hoffmann- La Roche, GlaxoSmith Kline, plc, Novartis AG, and Merck and Co. among others.

Market Segmentation

Market By Product

  • Lamivudine
  • Hepatitis B vaccine
  • Anti-Viral Drugs
  • Acyclovir
  • Fascornet
  • Adefovir
  • Entecavir
  • Tenofovir
  • Famciclovir
  • Telbivudine

Market By End Use

  • Hospitals pharmacies
  • Pharmacies
  • Drug stores
  • Clinics

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Cart Summary